… testified both for inpatients with COVID-19 in regular ward and … COVID-19 in ICU. On the
other hand, although we reported several useful actions of heparin for inpatients with COVID-19, …

… with Covid-19, a majority have involved the use of heparin or … therapeutic heparin as compared
with prophylactic heparin or … , the potential benefits and risks of therapeutic-dose heparin …

… use of heparin in COVID-19 patients, nebulised heparin has … for different stages of COVID-19
disease (van Haren et al., … evaluate the potential mechanism by which heparin might inhibit …

… COVID and acute COVID should benefit from treatment with HELP apheresis, which is in
clinical use for 37 years. COVID-19 … shows it cannot inflict harm upon patients with COVID-19. …

… that LMW heparin has the potential to relieve inflammation in COVID-19 patients: in a
retrospective cohort study, Shi et al. demonstrated that the use of LMW heparin was associated …

… Nevertheless, the trial was predicated on anticipated potential benefit in both moderately …
of greater potential risk of thrombosis in critically ill patients, suggesting greater potential benefit…

… different heparin doses in patients with COVID-19. Thachil reported that heparin in patients
with COVID-19 has potential … protective effects and that heparin decreased ARDS, increased …

… drugs against COVID-19, is commendable. Particularly, we read with interest the authors’
viewpoints regarding the potential therapeutic roles of colchicine in patients with COVID-19, …

… with COVID-19, therapeutic heparin (unfractionated heparin [UFH] or low-molecular-weight
heparin … insights in describing the potential role of therapeutic heparin in patients with COVID-…

… In conclusion, in the cohort of patients with Covid-19 treated with … potential unknown or
unrecorded confounders, such as an increased experience in the care of patients with Covid-19 …